One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes
ConclusionHCL system (MiniMed 670G) in children and adolescents previously treated with MDI significantly improves glycemic outcomes (HbA1c and Time in Ranges) immediately during the first month. This improved glycemic control was maintained over the 1 year following Auto Mode initiation.
Source: Acta Diabetologica - Category: Endocrinology Source Type: research
More News: Children | Diabetes | Diabetes Type 1 | Endocrinology | Middle East Health | Pediatrics | Qatar Health | Study